The antiviral activity of antibodies in vitro and in vivo. (Q34212487)

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Kinetics of sensitization of herpes simplex virus and its relationship to the reduction in the neutralization rate constant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Kinetics of neutralization of sensitized herpes simplex virus with antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

The role of antibody concentration and avidity in antiviral protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Lack of quantitative correlation between the neutralization of poliovirus and the antibody-mediated pI shift of the virions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in Vivo by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antibody and virus: binding and neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Human antibody effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

A multi-hit model for the neutralization of animal viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antigenic variation and resistance to neutralization in poliovirus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Molecular farming of recombinant antibodies in plants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Mechanisms of Rabies Virus Neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antibody-mediated activation of sindbis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Refined structure of an intact IgG2a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

The enhancement of virus infectivity by antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Mechanism of Antibody-Mediated Protection against Herpes Simplex Virus Infection in Athymic Nude Mice: Requirement of Fc Portion of Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Nonrandom association of cellular antigens with HTLV-III virions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralization of poliovirus by a monoclonal antibody: Kinetics and stoichiometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Extracellular enveloped vaccinia virus escapes neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Phenotypic mixing of vesicular stomatitis virus with HVJ (Sendai virus).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Inhibition of the complement cascade by the major secretory protein of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

THE INTERACTION BETWEEN VIRUS AND ANTIBODY. I. KINETIC STUDIES.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

THE INTERACTION BETWEEN VIRUS AND ANTIBODY. II. MECHANISM OF THE REACTION.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

A recombinant single chain antibody neutralizes coronavirus infectivity but only slightly delays lethal infection of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Brief report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antigen-specific human antibodies from mice comprising four distinct genetic modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Viral interference with antibody and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Reversibility of the reaction between polio-virus and neutralizing antibody of rabbit origin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralization of poliovirus: A hypothesis to explain the mechanism and the one-hit character of the neutralization reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Complement Enhancement of Neutralizing Antibody to the Structural Proteins of Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Immunological studies of the functions of paramyxovirus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protection against Zosteriform Spread of Herpes Simplex Virus by Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protection of mice against Sendai virus pneumonia by non-neutralizing anti-F monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Profiles of antibody-dependent enhancement of dengue virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

HIV-1 antibody--debris or virion?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralization of Chlamydia trachomatis: kinetics and stoichiometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Interaction between poliovirus and immunoglobulins. II. Basic aspects of virus-antibody interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Interaction between poliovirus and immunoglobulins. I. Detection of virus antibodies by partition in aqueous polymer phase systems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Transgenic milk as a method for the production of recombinant antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

An analysis of the inactivation of MS2 bacteriophage with antiserum.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Epitopes of the CD4 antigen and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in sindbis virus E1 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Rapidity of specific antibody-antigen interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Vaccinia virus immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Neutralization of cytomegalovirus virions: the role of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Recent structural solutions for antibody neutralization of viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Role of complement in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Towards a vaccine against AIDS: lessons from simian immunodeficiency virus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Quantitative relationships between an influenza virus and neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Viral subversion of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Electron microscopic studies on the structure of rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Herpesvirus neutralization: Induction of the persistent fraction by insufficient antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Decreased Expression of the Membrane Inhibitor of Complement-Mediated Cytolysis CD59 on T-lymphocytes of HIV-Infected Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

The neutralization of arboviruses. I. Neutralization homologous virus-serum mixtures with two group B arboviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Vesicular stomatitis virus (measles) pseudotypes: tool for demonstrating defective measles infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Epitopes involved in antibody-mediated protection from Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Dimeric association and segmental variability in the structure of human CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2801%2977018-6

7 January 2021

Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo

1 reference

12 December 2020

Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody

1 reference

12 December 2020

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

12 December 2020

Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats.

1 reference

12 December 2020

Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection

1 reference

12 December 2020

Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing)

1 reference

12 December 2020

Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site

1 reference

12 December 2020

HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.

1 reference

12 December 2020

Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth

1 reference

12 December 2020

Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor

1 reference

12 December 2020

Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein

1 reference

12 December 2020

Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, inclu

1 reference

12 December 2020

Challenges for development of hepatitis C virus vaccines

1 reference

12 December 2020

Python: a programming language for software integration and development

1 reference

12 December 2020

Neutralization of animal viruses

1 reference

12 December 2020

Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope

1 reference

12 December 2020

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

1 reference

12 December 2020

Ebola virus can be effectively neutralized by antibody produced in natural human infection

1 reference

12 December 2020

Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system

1 reference

12 December 2020

Phenotypic mixing of vesicular stomatitis virus with fowl plague virus

1 reference

12 December 2020

Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses

1 reference

12 December 2020

Assembly and morphology of HIV: potential effect of structure on viral function

1 reference

12 December 2020

Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies

1 reference

12 December 2020

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins

1 reference

12 December 2020

A study of passive immunization against a transplanted G+ leukemia with specific antiserum

1 reference

12 December 2020

Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection

1 reference

12 December 2020

Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies

1 reference

12 December 2020

A mathematical and experimental study of the kinetics of neutralization of bacteriophage phi chi 174 by antibodies

1 reference

12 December 2020

An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31.

1 reference

12 December 2020

Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H

1 reference

12 December 2020

Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients

1 reference

12 December 2020

Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus

1 reference

12 December 2020

Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus

1 reference

12 December 2020

Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia.

1 reference

12 December 2020

Reduced surface: an efficient way to compute molecular surfaces

1 reference

12 December 2020

Antibody interactions with rhinovirus: lessons for mechanisms of neutralization and the role of immunity in viral evolution

1 reference

12 December 2020

Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.

1 reference

12 December 2020

Interaction of the poliovirus receptor with poliovirus

1 reference

12 December 2020

Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis

1 reference

12 December 2020

Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.

1 reference

12 December 2020

Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies

1 reference

12 December 2020

The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity

1 reference

12 December 2020

Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

1 reference

12 December 2020

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

12 December 2020

Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1

1 reference

12 December 2020

Role of mucosal antibodies in viral infections

1 reference

12 December 2020

Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus.

1 reference

12 December 2020

A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses

1 reference

12 December 2020

Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases

1 reference

12 December 2020

Role of cell-associated enveloped vaccinia virus in cell-to-cell spread

1 reference

12 December 2020

Beijerinck's contribution to the virus concept--an introduction

1 reference

12 December 2020

Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness

1 reference

12 December 2020

Antibody-induced restriction of viral gene expression in measles encephalitis in rats

1 reference

12 December 2020

Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri.

1 reference

12 December 2020

Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection

1 reference

12 December 2020

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

12 December 2020

The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation

1 reference

12 December 2020

A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion

1 reference

12 December 2020

Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene

1 reference

12 December 2020

Human antibodies from combinatorial libraries.

1 reference

12 December 2020

Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo

1 reference

12 December 2020

Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection

1 reference

12 December 2020

Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms

1 reference

12 December 2020

Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens

1 reference

12 December 2020

Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody

1 reference

12 December 2020

Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2

1 reference

12 December 2020

Integrating computation and visualization for biomolecular analysis: an example using python and AVS.

1 reference

12 December 2020

Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation

1 reference

12 December 2020

Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes

1 reference

12 December 2020

The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity

1 reference

12 December 2020

Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization

1 reference

12 December 2020

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

12 December 2020

Protection from lethal coronavirus infection by immunoglobulin fragments

1 reference

12 December 2020

Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments

1 reference

12 December 2020

Protective immune response against foot-and-mouth disease

1 reference

12 December 2020

Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence

1 reference

12 December 2020

Preparation of genetically engineered monoclonal antibodies for human immunotherapy

1 reference

12 December 2020

The characterization and uses of monoclonal antibodies to respiratory syncytial virus

1 reference

12 December 2020

Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin

1 reference

12 December 2020

Viral spread in the presence of neutralizing antibody: mechanisms of persistence in foamy virus infection

1 reference

12 December 2020

Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection of cotton rats

1 reference

12 December 2020

Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization

1 reference

12 December 2020

Structural studies on antibody interacting with viruses

1 reference

12 December 2020

Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

1 reference

12 December 2020

Virus aggregation as the cause of the non-neutralizable persistent fraction

1 reference

12 December 2020

Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies.

1 reference

12 December 2020

Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model

1 reference

12 December 2020

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

12 December 2020

Immune enhancement of viral infection

1 reference

12 December 2020

Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells

1 reference

12 December 2020

Three-dimensional structure of poliovirus receptor bound to poliovirus

1 reference

12 December 2020

Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy.

1 reference

12 December 2020

Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus

1 reference

12 December 2020

Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation

1 reference

12 December 2020

Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization

1 reference

12 December 2020

Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1

1 reference

12 December 2020

Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines

1 reference

12 December 2020

Opsonization-enhanced phagocytosis of foot-and-mouth disease virus

1 reference

12 December 2020

Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies

1 reference

12 December 2020

Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or

1 reference

12 December 2020

Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1

1 reference

12 December 2020

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.

1 reference

12 December 2020

HIV entry and tropism: the chemokine receptor connection.

1 reference

12 December 2020

Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice

1 reference

12 December 2020

Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease

1 reference

12 December 2020

Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons

1 reference

12 December 2020

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

12 December 2020

Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus

1 reference

12 December 2020

Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

1 reference

12 December 2020

Natural variation of poliovirus neutralization epitopes

1 reference

12 December 2020